Literature DB >> 23255890

DNA hypomethylation of interleukin 8 in clear cell renal cell carcinoma.

Koo Han Yoo1, Yong-Koo Park, Sung-Goo Chang.   

Abstract

DNA hypomethylation is associated with carcinogenesis due to its involvement in cancer initiation and progression. In this study we analyzed the hypomethylation status of candidate genes in clear cell renal cell carcinoma (CCRCC) using a large-scale, high-throughput DNA methylation profiling technique. Results revealed that hypomethylated interleukin 8 (IL8) gene was the most prominent of the candidate genes, with a beta value difference of 0.406 (cancer tissue mean beta value, 0.346; normal tissue mean beta value, 0.752). Validation results using sequencing analysis demonstrated that the methylation rate was 2.4% in cancer tissue and 14.7% in normal tissue, whilst the non-methylation rate was 82.9% in cancer tissue and 52.9% in normal tissue. However, the hypomethylation status of IL8 had no significant relationship with Fuhrman's nuclear grade, tumor node metastasis (TNM) stage or survival (P>0.05). We revealed that the IL8 gene is maximally hypomethylated in cancer tissue compared to normal tissue.

Entities:  

Year:  2012        PMID: 23255890      PMCID: PMC3525470          DOI: 10.3892/ol.2012.992

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  18 in total

1.  Chromosomal instability and tumors promoted by DNA hypomethylation.

Authors:  Amir Eden; François Gaudet; Alpana Waghmare; Rudolf Jaenisch
Journal:  Science       Date:  2003-04-18       Impact factor: 47.728

2.  Prognostic significance of vascular endothelial growth factor expression in clear cell renal cell carcinoma.

Authors:  Gordana Djordjevic; Vladimir Mozetic; Danijela Vrdoljak Mozetic; Vanja Licul; Koviljka Matusan Ilijas; Elvira Mustac; Romano Oguic; Zeljko Fuckar; Nives Jonjic
Journal:  Pathol Res Pract       Date:  2007       Impact factor: 3.250

3.  Genetic disruption of cytosine DNA methyltransferase enzymes induces chromosomal instability in human cancer cells.

Authors:  Adam R Karpf; Sei-ichi Matsui
Journal:  Cancer Res       Date:  2005-10-01       Impact factor: 12.701

Review 4.  Interleukin-8 and human cancer biology.

Authors:  K Xie
Journal:  Cytokine Growth Factor Rev       Date:  2001-12       Impact factor: 7.638

5.  Genome-wide hypomethylation in human glioblastomas associated with specific copy number alteration, methylenetetrahydrofolate reductase allele status, and increased proliferation.

Authors:  Benoît Cadieux; Tsui-Ting Ching; Scott R VandenBerg; Joseph F Costello
Journal:  Cancer Res       Date:  2006-09-01       Impact factor: 12.701

Review 6.  CXC chemokines in angiogenesis of cancer.

Authors:  Robert M Strieter; John A Belperio; Roderick J Phillips; Michael P Keane
Journal:  Semin Cancer Biol       Date:  2004-06       Impact factor: 15.707

7.  DNA hypomethylation arises later in prostate cancer progression than CpG island hypermethylation and contributes to metastatic tumor heterogeneity.

Authors:  Srinivasan Yegnasubramanian; Michael C Haffner; Yonggang Zhang; Bora Gurel; Toby C Cornish; Zhijin Wu; Rafael A Irizarry; James Morgan; Jessica Hicks; Theodore L DeWeese; William B Isaacs; G Steven Bova; Angelo M De Marzo; William G Nelson
Journal:  Cancer Res       Date:  2008-11-01       Impact factor: 12.701

8.  Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands.

Authors:  J G Herman; J R Graff; S Myöhänen; B D Nelkin; S B Baylin
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-03       Impact factor: 11.205

9.  Atypical methylation of the interleukin-8 gene correlates strongly with the metastatic potential of breast carcinoma cells.

Authors:  Joseph E De Larco; Beverly R K Wuertz; Douglas Yee; Brenda L Rickert; Leo T Furcht
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-17       Impact factor: 11.205

10.  DNA promoter methylation status and protein expression of interleukin-8 in human colorectal adenocarcinomas.

Authors:  Jan Dimberg; Karin Ström; Sture Löfgren; Niklas Zar; Mikael Lindh; Andreas Matussek
Journal:  Int J Colorectal Dis       Date:  2011-11-24       Impact factor: 2.571

View more
  4 in total

Review 1.  Role of DNA methylation in renal cell carcinoma.

Authors:  Niraj Shenoy; Nishanth Vallumsetla; Yiyu Zou; Jose Nahun Galeas; Makardhwaj Shrivastava; Caroline Hu; Katalin Susztak; Amit Verma
Journal:  J Hematol Oncol       Date:  2015-07-22       Impact factor: 17.388

2.  Expression of interleukine-8 as an independent prognostic factor for sporadic colon cancer dissemination.

Authors:  A Nastase; L Paslaru; V Herlea; M Ionescu; D Tomescu; N Bacalbasa; S Dima; I Popescu
Journal:  J Med Life       Date:  2014-06-25

3.  Integrated microRNA and mRNA Signature Associated with the Transition from the Locally Confined to the Metastasized Clear Cell Renal Cell Carcinoma Exemplified by miR-146-5p.

Authors:  Zofia Wotschofsky; Linda Gummlich; Julia Liep; Carsten Stephan; Ergin Kilic; Klaus Jung; Jean-Noel Billaud; Hellmuth-Alexander Meyer
Journal:  PLoS One       Date:  2016-02-09       Impact factor: 3.240

4.  Promoter DNA methylation analysis reveals a novel diagnostic CpG-based biomarker and RAB25 hypermethylation in clear cell renel cell carcinoma.

Authors:  Yinmin Gu; Yi Ming Zou; Danqing Lei; Yuanjie Huang; Weidong Li; Zengnan Mo; Yanling Hu
Journal:  Sci Rep       Date:  2017-10-27       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.